Share Talk speak to #AMYT CEO Joe Wiley about their recent 'Transformational Licence Agreement' RNS of 5 Dec 2016. We also get some more background information about Amryt Pharma and their focus on best-in-class treatments for rare and orphan diseases.

Amryt Pharma, Joe Wiley CEO

OrderedDict([('@audioboom:html', '1'), ('#text', '<p>Designed for Private - Retail Investors, bloggers, brokers, PR, listed companies to communicate on one information portal. Please note we are an unregulated website and will never give out advice. We are here to make investing a level playing field.</p>')])

Business

Investing

Business News

OrderedDict([('@audioboom:html', '1'), ('#text', 'Designed for Private - Retail Investors, bloggers, brokers, PR, listed companies to communicate on one information portal. Please note we are an unregulated website and will never give out advice. We are here to make investing a level playing field.')])

Share Amryt Pharma, Joe Wiley CEO

Sign up to save your podcasts

Amryt Pharma, Joe Wiley CEO

Amryt Pharma, Joe Wiley CEO

More shows like Share Talk LTD

The SharePickers Podcast with Justin Waite

Investors' Chronicle

This is Money Podcast

Money Makers

The Personal Investor

State of the Markets

CONKERS' CORNER

PIWORLD Investor Podcasts

AJ Bell Money & Markets

On The Money

The Investor Way

The Vox Markets Podcast

The Sunday Roast

UK Small/Mid Caps Podcast with Paul Scott

Merryn Talks Money